The possible diagnosis of ‘maladie du col vésical’ has been made on 46 children. This bladder-neck obstruction was not secondary (no intracervical obstruction). All the diagnostic criteria are reviewed: post-micturition residual, bladder trabeculations and diverticulum, endoscopic aspect of the neck, during micturating cystourethrogram and transvesical operation, pathology of the bladder-neck. None of the criteria is absolutely certain in proving bladder-neck obstruction. The review of literature on this subject is also very confusing. The results of treatment are difficult to evaluate because reimplantation of the ureter(s) has often been done at the same time. The resection of the posterior lip of the Y–V plasty done without ureterocystoneostomy, never eliminate vesicoureteral reflux or improves the upper urinary tract. Several post-operative complications (urinary incontinence, epididymitis) have been seen and aggravate the pronostic. The ‘maladie du col vésical’ seems to be a rare disease. It is difficult to make the diagnostic and the treatment is not without danger.

Keywords:
Pediatric urology, Urinary retention, Urinary infection, Bladder-neck obstruction
This content is only available via PDF.
© 1972 S. Karger AG, Basel
1972
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.